Market cap
$564 Mln
Revenue (TTM)
$519 Mln
P/E Ratio
24.1
P/B Ratio
2.1
Div. Yield
0.3 %
Quality Score
/10
Growth Score
/10
Valuation Score
/10
Momentum Score
/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$21 Mln
-
ROE
0.1 %
-
ROCE
6.9 %
-
Industry P/E
--
-
EV/EBITDA
11.5
-
Debt to Equity
0.4
-
Book Value
$--
-
EPS
$0.5
-
Face value
--
-
Shares outstanding
45,884,542
10 Years Aggregate
CFO
$1,124.25 Mln
EBITDA
$1,337.35 Mln
Net Profit
$679.64 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Core Laboratories NV (CLB)
| -25.2 | 2.7 | -15.7 | 8.1 | -20.3 | -15.4 | -20.4 |
|
BSE Sensex*
| -8.3 | 2.1 | 2.2 | -3.9 | 6.2 | 6.8 | 10.8 |
|
Company
|
2025
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|
|
Core Laboratories NV (CLB)
| -7.4 | -12.9 | -9.1 | -15.8 | -29.6 | -36.9 |
|
BSE Sensex
| 9.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
|
BSE Sensex
| 9.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Core Laboratories NV (CLB)
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement... segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas. Read more
-
Chairman of the Board, CEO, President & COO
Mr. Lawrence V. Bruno
-
Chairman of the Board, CEO, President & COO
Mr. Lawrence V. Bruno
-
Headquarters
Houston, TX
-
Website
FAQs for Core Laboratories NV (CLB)
What is the current share price of Core Laboratories NV (CLB) Today?
The share price of Core Laboratories NV (CLB) is $11.99 (NYSE) as of 26-Aug-2026 16:00 EDT. Core Laboratories NV (CLB) has given a return of -20.32% in the last 3 years.
What is the current PB & PE ratio of Core Laboratories NV (CLB)?
The P/E ratio of Core Laboratories NV (CLB) is 24.10 times as on 21-Aug-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
25.12 |
2.80 |
2024 |
26.34 |
3.28 |
2023 |
22.90 |
3.74 |
2022 |
48.79 |
5.15 |
2021 |
53.07 |
6.69 |
What is the 52 Week High and Low of Core Laboratories NV (CLB)?
The 52-week high and low of Core Laboratories NV (CLB) are Rs 20.36 and Rs 9.79 as of 27-Aug-2026.
What is the market cap of Core Laboratories NV (CLB)?
Core Laboratories NV (CLB) has a market capitalisation of $ 564 Mln as on 21-Aug-2026. As per SEBI classification, it is a company.
Should I invest in Core Laboratories NV (CLB)?
Before investing in Core Laboratories NV (CLB), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.